Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis

International Archives of Allergy and Immunology

Volumn 147, Issue 3, 2008, Pages 206-212

  Fukushima, Atsuki ^a   Sumi, Tamaki ^a   Ishida, Waka ^a   Yamada, Jun ^b   Iwakura, Yoichiro ^c   Ueno, Hisayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Conjunctivitis, allergic; Eosinophil; IL 17; T cell

Indexed keywords

ALUMINUM POTASSIUM SULFATE; EYE DROPS; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; RAGWEED ANTIGEN;

ADOPTIVE TRANSFER; ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CELL INFILTRATION; CELL STIMULATION; CONJUNCTIVA; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; EOSINOPHIL; HISTOPATHOLOGY; IMMUNOASSAY; IMMUNOPATHOGENESIS; IN VITRO STUDY; INFLAMMATORY CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROVOCATION TEST; RAGWEED; RECIPIENT; SPLEEN; SPLEEN CELL; TH2 CELL; WILD TYPE;

ADOPTIVE TRANSFER; AMBROSIA; ANIMALS; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; T-LYMPHOCYTES;

EID: 54249156559     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142043     Document Type: Article

References (17)

1. Ehlers WH, Donshik PC: Allergic ocular disorders: a spectrum of diseases. CLAO J 1992;18:117-124.
2. Bonini S, Magrini L, Rotiroti G, Lambiase A, Tomassini M, Rumi C, Bonini S: The eosinophil and the eye. Allergy 1997;52:44-47.
3. Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K: Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 1999;103:1220-1221.
4. Fukushima A, Yoshida H, Iwamoto H, Yoshida O, Ueno H: The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivitis (EAC) in rats. Exp Eye Res 1997;65:631-637.
5. Yoshida O, Yoshida H, Iwamoto H, Nishino K, Fukushima A, Ueno H: Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res 1999;18:117-124.
6. Iwamoto H, Nishino K, Magone TM, Whitcup SM, Yoshida O, Yoshida H, Ozaki A, Fukushima A, Ueno H: Experimental immune-mediated blepharoconjunctivitis in rats induced by immunization with ragweed pollen. Graefes Arch Clin Exp Ophthalmol 2000;238:346-351.
7. Fukushima A, Ozaki A, Fukata K, Ishida W, Ueno H: Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis. Invest Ophthalmol Vis Sci 2003;44:4366-4374.
8. Fukushima A, Ozaki A, Jian Z, Ishida W, Fukata K, Ueno H, Liu FT: Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice. Curr Eye Res 2005;30:241-248.
9. Ozaki A, Seki Y, Fukushima A, Kubo M: The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J Immunol 2005;175:5489-5497.
10. Fukushima A, Yamaguchi T, Ishida W, Fukata K, Taniguchi T, Liu FT, Ueno H: Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice. Exp Eye Res 2006;82:210-218.
11. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-748.
12. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ: Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003;198:1951-1957.
13. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y: Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002;17:375-387.
14. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, Fossiez F, Ryffel B, Schnyder B: Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006;203:2715-2725.
15. Harrington LE, Mangan PR, Weaver CT: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006;18:349-356.
16. Magone MT, Whitcup SM, Fukushima A, Chan CC, Silver PB, Rizzo LV: The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis. J Allergy Clin Immunol 2000;105:299-308.
17. Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK: Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 2005;171:12-18.